91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Advantages and disadvantages of using historical controls, and how data can be analysed using Bayesian statistics to develop a ‘predictive understanding’ of a drug.
-
In this interview with the Business Post, Steve Cutler discusses 91黑料’s overall business growth in Asia and the opportunity for growth in South Korea.
-
CFO Brendan Brennan comments in this article from the Irish Times about the importance of the American market for Irish companies.
-
In this article in Applied Clinical Trials, Debbie Gilmore, Vice President, Strategic Alliance Management outlines how strategic partnerships and partnership-driven approaches to outsourcing can be used to navigate an increasingly complex clinical research landscape.
-
In this article, 91黑料's Louisa Steinberg and Maureen Glynn consider the role of digital therapeutics in the treatment of central nervous system conditions and how they can be used to improve clinical trials.
-
Vesta Marciulioniene, Director, Global Regulatory Clinical Services and Jo Hulbert, Executive Director, Global Regulatory Clinical Services provide an overview of the EMA’s new framework on computerised systems and electronic data in clinical trials in this article from XTalks Clinical Edge.
-
This article from the Business Post reports that Icon plc has reported double-digit profit growth for the third quarter of 2023.
-
CFO Brendan Brennan is interviewed by Emmet Oliver on Newstalk’s Breakfast Business on 91黑料’s Q3 2023 financial results.
-
This episode of The Pharma Letter Podcast features an interview with 91黑料’s Chief Commercial Officer, George McMillan, who outlines how 91黑料 is growing in size to take advantage of increasing demand for its services.
-
This article provides details on recent 91黑料 plc collaboration with Tufts CSDD on a pilot study that seeks to validate new and more granular outsourcing model classifications in differentiating performance across custom contract-service approaches.
